Processa Pharmaceuticals (PCSA) said Tuesday it has priced a public offering to raise $7 million, with H.C. Wainwright as its placement agent.
The company said it is offering 28 million shares and warrants to purchase up to the same number of shares at $0.25 per share and warrant. Investors can also buy pre-funded warrants in lieu.
Processa said it expects to close the offering June 18, with funds raised to be used for its phase 2 trial of NCG-Cap, and for working capital and general corporate purposes.
The shares were up over 27% in recent trading.
Price: 0.29, Change: +0.06, Percent Change: +27.32
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。